Clinical trial Recruiting at 1 site Interventional Ages 20 to 40 Men only

Nano-sized intracanal medications to reduce periapical inflammation after root canal retreatment

Official title: Modulation of Periapical Inflammation Following Nano-Calcium Hydroxide and Nano-Chitosan Intracanal Medications in Endodontic Retreatment Cases: A Randomized Controlled Clinical Trial

Run by Al-Azhar University · NCT07571837 · Data updated 2026-11-12

This trial tests whether nano-calcium hydroxide or nano-chitosan pastes can reduce periapical inflammation and post-operative pain in adults undergoing endodontic retreatment of single-rooted teeth.

More Post Operative Pain trials

Quick facts

Study typeInterventional
Ages20 Years to 40 Years
SexMen only
Enrollment63 (estimated)
SponsorAl-Azhar University
Academic / other
Locations1 site (Cairo, Nasr City)
StatusRecruiting
StartedOctober 8, 2026
Main results expectedApril 15, 2027
Study endsMay 30, 2027
Registry record updatedOctober 15, 2026
Trial IDNCT07571837 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with a single-rooted tooth that has failed prior endodontic therapy, a periapical radiolucency (PAI score 3 or 4), and no current pain or swelling are ideal candidates.

Probably not a fit

Patients with systemic disease, recent antibiotic use, pregnancy or lactation, non-restorable or fractured teeth, immature roots, resorption, sinus tract, or multi-rooted cases are unlikely to benefit from enrolling.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Sixty-three patients with previously treated single-rooted teeth and periapical radiolucency will be randomized into three equal groups to receive either nano-chitosan paste, nano-calcium hydroxide paste, or standard calcium hydroxide as intracanal medicament. Retreatment procedures include gutta-percha removal, standardized rotary instrumentation, irrigation, and microbiologic sampling before medicament placement. Group assignment is concealed using sequentially numbered opaque envelopes and simple randomization. Outcomes focus on periapical inflammation and post-operative pain following the intervention.

Why it matters

Potential benefit: If successful, these nano-formulations could reduce inflammation and pain after retreatment and promote better periapical healing compared with standard calcium hydroxide.

How similar studies have gone: Laboratory and some animal studies suggest nano-calcium hydroxide and chitosan have improved antimicrobial and anti-inflammatory properties, but clinical evidence in humans remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients have single rooted teeth with root canal form type I. Have previous endodontic therapy with failure. Have periapical radiolucency (PAI score of 3 or 4). Asymptomatic patients who had no pain or swelling, had a negative response to palpation and percussion.

Exclusion Criteria:

Patients who had received antibiotic therapy within the past 3 months. Pregnancy and lactation. Systemic disease. Physical or mental disability. Non-restorable teeth. Any signs of resorption, immature roots, fracture, sinus tract and dental anomaly

Where it's running

  • Al Azhar University
    Cairo, Nasr City, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.